A unique strength of the TNC is our ability to study analogous phenotypes in rare genetic populations and the corresponding
genetic animal models of disease.
Not exact matches
The identification
of these
genetic defects has fed back to create ever more realistic
animal models of the
diseases, as mentioned earlier for Huntington's
disease.
«Drug candidate stops extra bone growth in
animal model of rare,
genetic disease.»
The most important advancement in medicine in the last 25 years was the development
of genetic modeling in
animals, enabling us to figure out how fundamental mechanisms
of physiology and
disease work, such as in bone loss.
The discovery was made by developing a mouse
model of the
disease that enabled researchers to track which
of 15
genetic groups — or subclones —
of myeloma cells spread beyond their initial site in the
animals» hind legs.
Dr. Tarazi studies the behavioral,
genetic, molecular, and cellular mechanisms that mediate the actions
of dissimilar psychotropic drugs by using
animal models that mimic the core symptoms
of different neuropsychiatric
diseases.
We have learned a fair amount from the neurologic
genetic diseases, but we and others also studied these cells in the laboratory as well as in
animal models of brain injury.
His lab develops isogenic human pluripotent stem cells and transgenic
animals to
model disease, with the goal
of delineating novel approaches to influence outcomes for Huntington
disease (HD) and Fragile X Syndrome (FXS), the most common
genetic causes
of dementia and intellectual disability, respectively.
To build upon the encouraging early discoveries, Helmsley renewed and expanded its Crohn's funding for the Institute in 2013 to begin new work with three major aims: 1) continue studies
of individual genes to determine how
genetic differences between Crohn's patients and healthy individuals contribute to the
disease; 2) evaluate promising small molecules in
disease - relevant studies and prioritize insights from genetics to help develop novel therapeutics; and 3) begin basic experimentation in
animal models with Crohn's
disease to provide the data necessary to begin testing new therapies in humans.
The Jackson Laboratory Research scientist /
Animal models of human
disease, Mouse Mutant Resource,
Genetic Resource Science 2006 - present
Her address, «A New Medical Research
Model: Advancing Human and Animal Health Humanely,» will detail the concept of a new research model predicated on a meaningful commitment by both medical and veterinary researchers to work cooperatively together to address disease and disorders in humans and animals — evaluating genetic and environmental risk factors, sensitive diagnostic indicators and novel thera
Model: Advancing Human and
Animal Health Humanely,» will detail the concept
of a new research
model predicated on a meaningful commitment by both medical and veterinary researchers to work cooperatively together to address disease and disorders in humans and animals — evaluating genetic and environmental risk factors, sensitive diagnostic indicators and novel thera
model predicated on a meaningful commitment by both medical and veterinary researchers to work cooperatively together to address
disease and disorders in humans and
animals — evaluating
genetic and environmental risk factors, sensitive diagnostic indicators and novel therapies.